Document is current
Any future updates will be listed below
-
Authors
Zobel, Emilie H https://orcid.org/0000-0003-3318-7070
Wretlind, Asger https://orcid.org/0000-0001-6083-5227
Ripa, Rasmus S
Rotbain Curovic, Viktor https://orcid.org/0000-0002-4270-6701
von Scholten, Bernt J
Suvitaival, Tommi
Hansen, Tine W
Kjær, Andreas
Legido-Quigley, Cristina
Rossing, Peter
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03449654 at ClinicalTrials.govDocuments that mention this clinical trial
Effect of Liraglutide on Arterial Inflammation Assessed as [ <sup>18</sup> F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
https://doi.org/10.1161/circimaging.120.012174
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
https://doi.org/10.1136/bmjdrc-2021-002395
-
Funding
Funding for this research was provided by:
Novo Nordisk A/S
Skibsreder Per Henriksen, R. og hustrus fund
Steno Diabetes Center Copenhagen and Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet have provided internal funding
- License Information
